Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2004 Jun;80(3):167–173. doi: 10.1136/sti.2003.008441

Contraception choice for HIV positive women

H Mitchell 1, E Stephens 1
PMCID: PMC1744846  PMID: 15169996

Full Text

The Full Text of this article is available as a PDF (89.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S., Serufilira A., Gruber V., Kegeles S., Van de Perre P., Carael M., Coates T. J. Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health. 1993 May;83(5):705–710. doi: 10.2105/ajph.83.5.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen Susan, Meinzen-Derr Jareen, Kautzman Michele, Zulu Isaac, Trask Stanley, Fideli Ulgen, Musonda Rosemary, Kasolo Francis, Gao Feng, Haworth Alan. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS. 2003 Mar 28;17(5):733–740. doi: 10.1097/00002030-200303280-00012. [DOI] [PubMed] [Google Scholar]
  3. Andersson J. K., Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990 Aug;97(8):690–694. doi: 10.1111/j.1471-0528.1990.tb16240.x. [DOI] [PubMed] [Google Scholar]
  4. Andersson K., Odlind V., Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994 Jan;49(1):56–72. doi: 10.1016/0010-7824(94)90109-0. [DOI] [PubMed] [Google Scholar]
  5. Bigrigg A., Evans M., Gbolade B., Newton J., Pollard L., Szarewski A., Thomas C., Walling M. Depo Provera. Position paper on clinical use, effectiveness and side effects. Br J Fam Plann. 1999 Jul;25(2):69–76. [PubMed] [Google Scholar]
  6. Bongaarts J., Westoff C. F. The potential role of contraception in reducing abortion. Stud Fam Plann. 2000 Sep;31(3):193–202. doi: 10.1111/j.1728-4465.2000.00193.x. [DOI] [PubMed] [Google Scholar]
  7. Bounds Walli, Guillebaud John. Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plann Reprod Health Care. 2002 Apr;28(2):78–80. doi: 10.1783/147118902101195992. [DOI] [PubMed] [Google Scholar]
  8. Carlin E. M., Boag F. C. Women, contraception and STDs including HIV. Int J STD AIDS. 1995 Nov-Dec;6(6):373–386. doi: 10.1177/095646249500600601. [DOI] [PubMed] [Google Scholar]
  9. Cates W., Jr, Stone K. M. Family planning, sexually transmitted diseases and contraceptive choice: a literature update--Part I. Fam Plann Perspect. 1992 Mar-Apr;24(2):75–84. [PubMed] [Google Scholar]
  10. Cates W., Jr, Stone K. M. Family planning, sexually transmitted diseases and contraceptive choice: a literature update--Part II. Fam Plann Perspect. 1992 May-Jun;24(3):122–128. [PubMed] [Google Scholar]
  11. Clark R. A., Kissinger P., Bedimo A. L., Dunn P., Albertin H. Determination of factors associated with condom use among women infected with human immunodeficiency virus. Int J STD AIDS. 1997 Apr;8(4):229–233. doi: 10.1258/0956462971919976. [DOI] [PubMed] [Google Scholar]
  12. Clark R. A., Kissinger P., Williams T. Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus. Int J STD AIDS. 1996 Oct;7(6):439–442. doi: 10.1258/0956462961918275. [DOI] [PubMed] [Google Scholar]
  13. Dabis François, Ekpini Ehounou René. HIV-1/AIDS and maternal and child health in Africa. Lancet. 2002 Jun 15;359(9323):2097–2104. doi: 10.1016/S0140-6736(02)08909-2. [DOI] [PubMed] [Google Scholar]
  14. Daly C. C., Helling-Giese G. E., Mati J. K., Hunter D. J. Contraceptive methods and the transmission of HIV: implications for family planning. Genitourin Med. 1994 Apr;70(2):110–117. doi: 10.1136/sti.70.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Davis K. R., Weller S. C. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect. 1999 Nov-Dec;31(6):272–279. [PubMed] [Google Scholar]
  16. De Vincenzi I., Jadand C., Couturier E., Brunet J. B., Gallais H., Gastaut J. A., Goujard C., Deveau C., Meyer L. Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group. AIDS. 1997 Mar;11(3):333–338. doi: 10.1097/00002030-199703110-00011. [DOI] [PubMed] [Google Scholar]
  17. Desgrées-Du-Loû Annabel, Msellati Philippe, Viho Ida, Yao Angèle, Yapi Delphine, Kassi Pierrette, Welffens-Ekra Christiane, Mandelbrot Laurent, Dabis François, Ditrame Study Group Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995-2000. Int J STD AIDS. 2002 Jul;13(7):462–468. doi: 10.1258/09564620260079617. [DOI] [PubMed] [Google Scholar]
  18. Diaz T., Schable B., Chu S. Y. Relationship between use of condoms and other forms of contraception among human immunodeficiency virus-infected women. Supplement to HIV and AIDS Surveillance Project Group. Obstet Gynecol. 1995 Aug;86(2):277–282. doi: 10.1016/0029-7844(95)00144-g. [DOI] [PubMed] [Google Scholar]
  19. Dickinson B. D., Altman R. D., Nielsen N. H., Sterling M. L., Council on Scientific Affairs, American Medical Association Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol. 2001 Nov;98(5 Pt 1):853–860. doi: 10.1016/s0029-7844(01)01532-0. [DOI] [PubMed] [Google Scholar]
  20. Duckitt K., Shaw R. W. Is medical management of menorrhagia obsolete? Br J Obstet Gynaecol. 1998 Jun;105(6):569–572. doi: 10.1111/j.1471-0528.1998.tb10168.x. [DOI] [PubMed] [Google Scholar]
  21. Edwards J. E., Moore A. Implanon. A review of clinical studies. Br J Fam Plann. 1999 Jan;24(4 Suppl):3–16. [PubMed] [Google Scholar]
  22. Elliman A. Interactions with hormonal contraception. Br J Fam Plann. 2000 Apr;26(2):109-11, quiz 111,122. doi: 10.1783/147118900101194193. [DOI] [PubMed] [Google Scholar]
  23. Farr G., Gabelnick H., Sturgen K., Dorflinger L. Contraceptive efficacy and acceptability of the female condom. Am J Public Health. 1994 Dec;84(12):1960–1964. doi: 10.2105/ajph.84.12.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Feldblum P. J., Welsh M. J., Steiner M. J. Don't overlook condoms for HIV prevention. Sex Transm Infect. 2003 Aug;79(4):268–269. doi: 10.1136/sti.79.4.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fiore Josè Ramòn, Suligoi Barbara, Saracino Annalisa, Di Stefano Mariantonietta, Bugarini Roberto, Lepera Achiropita, Favia Anna, Monno Laura, Angarano Gioacchino, Pastore Giuseppe. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003 Oct 17;17(15):2169–2176. doi: 10.1097/00002030-200310170-00004. [DOI] [PubMed] [Google Scholar]
  26. Frank M. L., Bateman L., Poindexter A. N. Planned condom use by women with Norplant implants. Adv Contracept. 1993 Sep;9(3):227–232. doi: 10.1007/BF01982945. [DOI] [PubMed] [Google Scholar]
  27. Gazmararian J. A., Parker R. M., Baker D. W. Reading skills and family planning knowledge and practices in a low-income managed-care population. Obstet Gynecol. 1999 Feb;93(2):239–244. doi: 10.1016/s0029-7844(98)00431-1. [DOI] [PubMed] [Google Scholar]
  28. Hankins C., Tran T., Lapointe N. Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):479–487. doi: 10.1097/00042560-199808150-00010. [DOI] [PubMed] [Google Scholar]
  29. Hankins C., Tran T., Lapointe N. Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):479–487. doi: 10.1097/00042560-199808150-00010. [DOI] [PubMed] [Google Scholar]
  30. Howe J. E., Minkoff H. L., Duerr A. C. Contraceptives and HIV. AIDS. 1994 Jul;8(7):861–871. doi: 10.1097/00002030-199407000-00001. [DOI] [PubMed] [Google Scholar]
  31. Hubacher D., Lara-Ricalde R., Taylor D. J., Guerra-Infante F., Guzmán-Rodríguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 2001 Aug 23;345(8):561–567. doi: 10.1056/NEJMoa010438. [DOI] [PubMed] [Google Scholar]
  32. Kalichman S. C., Rompa D., Cage M. Factors associated with female condom use among HIV-seropositive women. Int J STD AIDS. 2000 Dec;11(12):798–803. doi: 10.1258/0956462001915318. [DOI] [PubMed] [Google Scholar]
  33. Kiddugavu Mohammed, Makumbi Fred, Wawer Maria J., Serwadda David, Sewankambo Nelson K., Wabwire-Mangen Fred, Lutalo Tom, Meehan Mary, Xianbin, Gray Ronald H. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS. 2003 Jan 24;17(2):233–240. doi: 10.1097/00002030-200301240-00014. [DOI] [PubMed] [Google Scholar]
  34. Kovacs A., Wasserman S. S., Burns D., Wright D. J., Cohn J., Landay A., Weber K., Cohen M., Levine A., Minkoff H. Determinants of HIV-1 shedding in the genital tract of women. Lancet. 2001 Nov 10;358(9293):1593–1601. doi: 10.1016/S0140-6736(01)06653-3. [DOI] [PubMed] [Google Scholar]
  35. Kraehenbuhl J. P., Wain-Hobson S. Breaching barriers. Nat Med. 1996 Oct;2(10):1080–1082. doi: 10.1038/nm1096-1080. [DOI] [PubMed] [Google Scholar]
  36. Magalhães Jarbas, Amaral Eliana, Giraldo Paulo Cesar, Simoes Jose Antonio. HIV infection in women: impact on contraception. Contraception. 2002 Aug;66(2):87–91. doi: 10.1016/s0010-7824(02)00332-3. [DOI] [PubMed] [Google Scholar]
  37. Marks G., Burris S., Peterman T. A. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999 Feb 25;13(3):297–306. doi: 10.1097/00002030-199902250-00001. [DOI] [PubMed] [Google Scholar]
  38. Martin H. L., Jr, Nyange P. M., Richardson B. A., Lavreys L., Mandaliya K., Jackson D. J., Ndinya-Achola J. O., Kreiss J. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1998 Oct;178(4):1053–1059. doi: 10.1086/515654. [DOI] [PubMed] [Google Scholar]
  39. Marx P. A., Spira A. I., Gettie A., Dailey P. J., Veazey R. S., Lackner A. A., Mahoney C. J., Miller C. J., Claypool L. E., Ho D. D. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med. 1996 Oct;2(10):1084–1089. doi: 10.1038/nm1096-1084. [DOI] [PubMed] [Google Scholar]
  40. Mati J. K., Hunter D. J., Maggwa B. N., Tukei P. M. Contraceptive use and the risk of HIV infection in Nairobi, Kenya. Int J Gynaecol Obstet. 1995 Jan;48(1):61–67. doi: 10.1016/0020-7292(94)02214-3. [DOI] [PubMed] [Google Scholar]
  41. Moss G. B., Clemetson D., D'Costa L., Plummer F. A., Ndinya-Achola J. O., Reilly M., Holmes K. K., Piot P., Maitha G. M., Hillier S. L. Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. J Infect Dis. 1991 Sep;164(3):588–591. doi: 10.1093/infdis/164.3.588. [DOI] [PubMed] [Google Scholar]
  42. Mostad S. B., Overbaugh J., DeVange D. M., Welch M. J., Chohan B., Mandaliya K., Nyange P., Martin H. L., Jr, Ndinya-Achola J., Bwayo J. J. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997 Sep 27;350(9082):922–927. doi: 10.1016/S0140-6736(97)04240-2. [DOI] [PubMed] [Google Scholar]
  43. Murphy D., Lynch M., Desmond N., Mulcahy F. M. Contraceptive practices in HIV seropositive females in Ireland. Int J STD AIDS. 1993 Mar-Apr;4(2):107–109. doi: 10.1177/095646249300400210. [DOI] [PubMed] [Google Scholar]
  44. Ouellet D., Hsu A., Qian J., Locke C. S., Eason C. J., Cavanaugh J. H., Leonard J. M., Granneman G. R. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. Br J Clin Pharmacol. 1998 Aug;46(2):111–116. doi: 10.1046/j.1365-2125.1998.00749.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Piscitelli S. C., Gallicano K. D. Interactions among drugs for HIV and opportunistic infections. N Engl J Med. 2001 Mar 29;344(13):984–996. doi: 10.1056/NEJM200103293441307. [DOI] [PubMed] [Google Scholar]
  46. Playle J. F. Concepts of compliance: understandings and approaches. Br J Fam Plann. 2000 Oct;26(4):213–219. doi: 10.1783/147118900101194823. [DOI] [PubMed] [Google Scholar]
  47. Richardson B. A., Morrison C. S., Sekadde-Kigondu C., Sinei S. K., Overbaugh J., Panteleeff D. D., Weiner D. H., Kreiss J. K. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS. 1999 Oct 22;13(15):2091–2097. doi: 10.1097/00002030-199910220-00012. [DOI] [PubMed] [Google Scholar]
  48. Ross A., Morgan D., Lubega R., Carpenter L. M., Mayanja B., Whitworth J. A. Reduced fertility associated with HIV: the contribution of pre-existing subfertility. AIDS. 1999 Oct 22;13(15):2133–2141. doi: 10.1097/00002030-199910220-00017. [DOI] [PubMed] [Google Scholar]
  49. Ryder R. W., Batter V. L., Nsuami M., Badi N., Mundele L., Matela B., Utshudi M., Heyward W. L. Fertility rates in 238 HIV-1-seropositive women in Zaire followed for 3 years post-partum. AIDS. 1991 Dec;5(12):1521–1527. doi: 10.1097/00002030-199112000-00016. [DOI] [PubMed] [Google Scholar]
  50. Selwyn P. A., Schoenbaum E. E., Davenny K., Robertson V. J., Feingold A. R., Shulman J. F., Mayers M. M., Klein R. S., Friedland G. H., Rogers M. F. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA. 1989 Mar 3;261(9):1289–1294. [PubMed] [Google Scholar]
  51. Sinei S. K., Fortney J. A., Kigondu C. S., Feldblum P. J., Kuyoh M., Allen M. Y., Glover L. H. Contraceptive use and HIV infection in Kenyan family planning clinic attenders. Int J STD AIDS. 1996 Jan-Feb;7(1):65–70. doi: 10.1258/0956462961917104. [DOI] [PubMed] [Google Scholar]
  52. Sinei S. K., Morrison C. S., Sekadde-Kigondu C., Allen M., Kokonya D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet. 1998 Apr 25;351(9111):1238–1241. doi: 10.1016/S0140-6736(97)10319-1. [DOI] [PubMed] [Google Scholar]
  53. Steiner M. J., Cates W., Jr, Warner L. The real problem with male condoms is nonuse. Sex Transm Dis. 1999 Sep;26(8):459–462. doi: 10.1097/00007435-199909000-00007. [DOI] [PubMed] [Google Scholar]
  54. Stephenson J. M. Systematic review of hormonal contraception and risk of HIV transmission: when to resist meta-analysis. AIDS. 1998 Apr 16;12(6):545–553. doi: 10.1097/00002030-199806000-00002. [DOI] [PubMed] [Google Scholar]
  55. Sturridge F., Guillebaud J. Gynaecological aspects of the levonorgestrel-releasing intrauterine system. Br J Obstet Gynaecol. 1997 Mar;104(3):285–289. doi: 10.1111/j.1471-0528.1997.tb11455.x. [DOI] [PubMed] [Google Scholar]
  56. Sunderland A., Minkoff H. L., Handte J., Moroso G., Landesman S. The impact of human immunodeficiency virus serostatus on reproductive decisions of women. Obstet Gynecol. 1992 Jun;79(6):1027–1031. [PubMed] [Google Scholar]
  57. Thonneau P., Goulard H., Goyaux N. Risk factors for intrauterine device failure: a review. Contraception. 2001 Jul;64(1):33–37. doi: 10.1016/s0010-7824(01)00215-3. [DOI] [PubMed] [Google Scholar]
  58. Trussell J., Warner D. L., Hatcher R. A. Condom slippage and breakage rates. Fam Plann Perspect. 1992 Jan-Feb;24(1):20–23. [PubMed] [Google Scholar]
  59. Van Damme Lut, Ramjee Gita, Alary Michel, Vuylsteke Bea, Chandeying Verapol, Rees Helen, Sirivongrangson Pachara, Mukenge-Tshibaka Léonard, Ettiègne-Traoré Virginie, Uaheowitchai Charn. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002 Sep 28;360(9338):971–977. doi: 10.1016/s0140-6736(02)11079-8. [DOI] [PubMed] [Google Scholar]
  60. Walsh T., Grimes D., Frezieres R., Nelson A., Bernstein L., Coulson A., Bernstein G. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet. 1998 Apr 4;351(9108):1005–1008. doi: 10.1016/s0140-6736(97)09086-7. [DOI] [PubMed] [Google Scholar]
  61. Wilkinson David, Tholandi Maya, Ramjee Gita, Rutherford George W. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. Lancet Infect Dis. 2002 Oct;2(10):613–617. doi: 10.1016/s1473-3099(02)00396-1. [DOI] [PubMed] [Google Scholar]
  62. Wilson T. E., Massad L. S., Riester K. A., Barkan S., Richardson J., Young M., Gurtman A., Greenblatt R. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS. 1999 Apr 1;13(5):591–598. doi: 10.1097/00002030-199904010-00008. [DOI] [PubMed] [Google Scholar]
  63. de Souza Alison, Brechin Susan, Penney Gillian. The members' enquiry service: frequently asked questions. J Fam Plann Reprod Health Care. 2003 Oct;29(4):225–226. doi: 10.1783/147118903101197845. [DOI] [PubMed] [Google Scholar]
  64. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994 Aug 11;331(6):341–346. doi: 10.1056/NEJM199408113310601. [DOI] [PubMed] [Google Scholar]
  65. von Hertzen Helena, Piaggio Gilda, Ding Juhong, Chen Junling, Song Si, Bártfai György, Ng Ernest, Gemzell-Danielsson Kristina, Oyunbileg Amindavaa, Wu Shangchun. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002 Dec 7;360(9348):1803–1810. doi: 10.1016/S0140-6736(02)11767-3. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES